Bioactivity:

EGFR-IN-542 is a novel EGFR inhibitor. EGFR-IN-542 significantly reduces myocardial inflammation, fibrosis, apoptosis and dysfunction. It shows promise for use in the treatment of obesity-induced cardiac complications.

CAS nr:

1639040-81-5

Purity:

98%

Molecular Weight:

383,43

SMILES:

NC1=CC2=C(NC3=CC4=C(N(CC5=CC=CC(F)=C5)C=C4)C=C3)N=CN=C2C=C1

Formula:

C23H18FN5

Pathway:

Target: